Mauritius is the first country to show it is reversing the type 2 diabetes epidemic using gold-standard testing
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2 and published in The Lancet Diabetes & Endocrinology shows that the small island nation of Mauritius is the first country to demonstrate that it is reversing the type 2 diabetes epidemic using the gold-standard two-hour oral glucose tolerance test (2 hour…
New research presented at the European Association for the Study of Diabetes conference in Milan reveals that Mauritius has become the first country to reverse its Type 2 diabetes epidemic. The island nation, with a population of 1.2 million, has monitored diabetes prevalence through seven surveys conducted since 1987, using the gold-standard two-hour oral glucose tolerance test (2 hour OGTT).
While globally, the prevalence of Type 2 diabetes has been steadily increasing due to changes in living conditions and lifestyles, leading to a shift from infectious to chronic non-communicable diseases, Mauritius has seen a decline in both Type 2 diabetes and prediabetes prevalence. Between 1987 and 2009, the prevalence of Type 2 diabetes increased by 61% in men and 56% in women, but between 2009 and 2021, it decreased by 11% in men and 16% in women.
The researchers suggest that this reversal highlights the potential impact of diabetes prevention and management initiatives. They conclude that Mauritius is the first country to show a sustained decrease in Type 2 diabetes and prediabetes prevalence, based on long-term data using WHO-recommended diagnostic criteria.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
